South Korea Calls For ‘Mutually Beneficial’ Trade Deal With US

A biotech start-up is breaking new ground by developing vaccines specifically for bees and shrimp—marking the first time insect vaccines have been approved in the U.S. This could be a game-changer for protecting these crucial species from devastating diseases.

Editor’s Note: Bees and shrimp might seem like an odd pairing, but both are vital to our food supply—bees pollinate crops, and shrimp are a major aquaculture product. Diseases have been wiping them out at alarming rates, so vaccines could help stabilize ecosystems and economies. Plus, it’s a fascinating example of how biotech is solving problems we didn’t even realize we could tackle.

When you hear "biotech," you probably picture labs working on human diseases—not vaccines for bees or shrimp. But that’s exactly what Dalan Animal Health is doing. Their groundbreaking bee vaccine is already a reality, and they’re now tackling shrimp health too. CEO Annette Kleiser explains why keeping these critters healthy isn’t just niche science—it’s vital for ecosystems and our food supply.

Editor’s Note: This isn’t just quirky science—it’s a big deal. Bees pollinate a third of our crops, and shrimp are a global food staple. If diseases wipe them out, we’re in trouble. Dalan’s work could help stabilize fragile food chains and maybe even inspire more "outside-the-lab" biotech solutions. Plus, who knew shrimp could get vaccinated?

Stellantis, the parent company of brands like Jeep and Dodge, is recalling more than 250,000 vehicles in the U.S. because their airbags might not be properly sealed. According to the National Highway Traffic Safety Administration (NHTSA), this flaw could prevent the airbags from working correctly in a crash, raising safety concerns.

Editor’s Note: Recalls like this aren’t just bureaucratic red tape—they’re a big deal because airbags are a critical safety feature. If they fail, the risk of injury in an accident goes up. For Stellantis, it’s another headache in an industry already grappling with supply chain issues and quality control challenges. For drivers, it’s a reminder to check for recalls and get repairs done ASAP.

A new report from Standard Chartered throws cold water on the idea that simply flooding the market with cash will magically spark widespread lending. While extra liquidity might give a temporary bump to things like personal loans (think credit cards or buy-now-pay-later schemes), it doesn’t translate to broader credit growth across the economy. The real driver? Actual economic activity—when businesses and consumers are confident enough to borrow because they see opportunities, not just because money’s cheap. Historically, credit as a share of GDP actually shrinks during high-liquidity periods, which suggests demand, not supply, calls the shots.

Editor’s Note: This isn’t just banking jargon—it’s a reality check for anyone thinking central banks can fix sluggish growth by turning on the money taps alone. If people aren’t spending, businesses aren’t investing, and the economic mood is shaky, no amount of liquidity will change that. It’s like offering free gas to drivers who don’t have cars. The takeaway? Policies need to focus on firing up real demand, not just moving money around.

London’s Saucy Books is making waves as England’s first dedicated romance bookshop, offering everything from steamy billionaire dramas to fantastical dragon-riding love stories. While the shop’s opening highlights the genre’s booming popularity, fans argue that romance still battles unfair stereotypes and misogyny—despite its massive appeal.

Editor’s Note: Romance novels are having a moment, but they’re often dismissed as "guilty pleasures" rather than celebrated for what they are: wildly creative, inclusive, and just plain fun. Saucy Books isn’t just selling love stories—it’s pushing back against snobbery and giving readers a space to geek out without shame. For a genre that dominates bestseller lists, this shop is a long-overdue win.